Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 001203.SZ
Valuation Weak
28%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 49.72 0.43 0.29
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 50.90 16.26 10.77
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 4.03 4.07 3.91
Cash 235.27 0.72 0.22
Capex 94.40 -0.17 -2.98
Free Cash Flow -98.86 0.03 -2.60
Revenue -16.58 0.61 0.73
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 9.76 0.57 0.52
Operating Margin -21.66 0.31 0.39
ROA -28.65 0.02 0.02
ROE -25.76 0.04 0.05
ROIC -40.19 0.02 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 001203.SZ is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 001203.SZ is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 001203.SZ is permitted for members.